West Nile virus activity – United States, 2009.
- Journal Article
Summary
The research article discusses the activity of the West Nile Virus, a mosquito-borne disease, across the United States in 2009. It talks about the spread of the disease, the regions which were majorly affected, the age-group most susceptible, the nature of the disease, and the preventive measures that need to be adopted.
Summary of the West Nile Virus Activity in the U.S in 2009
In 1999, the West Nile virus (WNV) was first detected in the Western Hemisphere, specifically in New York City. It soon became the leading cause of arboviral encephalitis, causing regular seasonal epidemics. By 2009, it had spread across the country, with 720 cases of the WNV disease reported from 38 states and the District of Columbia (DC).
- The cases included 386 instances of WNV neuroinvasive disease reported from 33 states and DC.
- The incidence of this disease was 0.13 per 100,000 population.
- The five states with the highest incidence of WNV neuroinvasive disease were Mississippi, South Dakota, Wyoming, Colorado, and Nebraska.
Demographic Impact
According to the research, the incidence of WNV neuroinvasive disease increased with age. People aged 70 years and older were most susceptible to the disease.
- In 2009, 33 deaths were attributed to WNV, with 32 of them resulting from the neuroinvasive variety of the disease.
Disease Estimation and Prevention
Working with the data they had, the Center for Disease Control and Prevention (CDC) estimated that around 54,000 people were infected with WNV in 2009. Out of these people, approximately 10,000 developed nonneuroinvasive WNV disease.
- Considering the continued disease burden caused by West Nile Virus, the report underscores the importance of ongoing surveillance, mosquito control, promotion of personal protection from mosquito bites.
- It also suggests researching additional strategies for prevention.
This study sheds light on the impact of WNV in different components of the population and emphasizes the need for continued efforts to control and prevent the spread of this disease. It provides essential groundwork for the formulation of new strategies for disease management and prevention.
Cite This Article
Publication
Researcher Affiliations
MeSH Terms
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Animals
- Bird Diseases / epidemiology
- Birds
- Child
- Child, Preschool
- Culicidae / virology
- Female
- Horse Diseases / epidemiology
- Horses
- Humans
- Incidence
- Infant
- Male
- Middle Aged
- Population Surveillance
- United States / epidemiology
- West Nile Fever / complications
- West Nile Fever / diagnosis
- West Nile Fever / epidemiology
- West Nile virus
- Young Adult
Citations
This article has been cited 12 times.- Laperche S. Definition of emerging infectious diseases. ISBT Sci Ser 2011 Jul;6(1):112-115.
- Latif A, Kapoor V, Simmons E, Parekh J, Andukuri V. West Nile virus encephalitis in a young immunocompetent female in Omaha Nebraska. Intractable Rare Dis Res 2019 Feb;8(1):48-51.
- Muraki Y, Fujita T, Matsuura M, Fuke I, Manabe S, Ishikawa T, Okuno Y, Morita K. The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys. Virol J 2015 Apr 9;12:54.
- Staples JE, Shankar MB, Sejvar JJ, Meltzer MI, Fischer M. Initial and long-term costs of patients hospitalized with West Nile virus disease. Am J Trop Med Hyg 2014 Mar;90(3):402-9.
- Lindsey NP, Staples JE, Delorey MJ, Fischer M. Lack of evidence of increased West Nile virus disease severity in the United States in 2012. Am J Trop Med Hyg 2014 Jan;90(1):163-8.
- Duggal NK, D'Anton M, Xiang J, Seiferth R, Day J, Nasci R, Brault AC. Sequence analyses of 2012 West Nile virus isolates from Texas fail to associate viral genetic factors with outbreak magnitude. Am J Trop Med Hyg 2013 Aug;89(2):205-210.
- . West Nile virus and other arboviral diseases--United States, 2012. MMWR Morb Mortal Wkly Rep 2013 Jun 28;62(25):513-7.
- Kumar P, Singh SK, Singh YR, Jhala MK. A brief view on molecular diagnosis and surveillance of west nile virus. Avicenna J Med Biotechnol 2010 Oct;2(4):223-4.
- Lindsey NP, Staples JE, Lehman JA, Fischer M. Medical risk factors for severe West Nile Virus disease, United States, 2008-2010. Am J Trop Med Hyg 2012 Jul;87(1):179-84.
- Lindsey NP, Brown JA, Kightlinger L, Rosenberg L, Fischer M. State health department perceived utility of and satisfaction with ArboNET, the U.S. National Arboviral Surveillance System. Public Health Rep 2012 Jul-Aug;127(4):383-90.
- Cregar-Hernandez L, Jiao GS, Johnson AT, Lehrer AT, Wong TA, Margosiak SA. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Antivir Chem Chemother 2011 May 12;21(5):209-17.
- Debiasi RL. West nile virus neuroinvasive disease. Curr Infect Dis Rep 2011 Aug;13(4):350-9.